Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| The Fulham Shore Plc | LSE:FUL | London | Ordinary Share | GB00B9F8VG44 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.05 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 14.05 | GBX |
The Fulham Shore (FUL) Share Charts1 Year The Fulham Shore Chart |
|
1 Month The Fulham Shore Chart |
Intraday The Fulham Shore Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/7/2023 | 17:56 | The Fulham Shore PLC | 378 |
| 26/7/2012 | 19:58 | Fulcrum Pharma - drug development to regulatory approval (1.1.07) | 631 |
| 21/2/2007 | 07:41 | FULCRUM IN PROFIT & GROWING | 1,807 |
| 17/4/2004 | 18:56 | Strong buy - FUL Pharma - profit and turnover up x 10 fold | 13 |
| 01/5/2003 | 08:14 | Fulcrum Pharma (FUL) | 1,061 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 05/4/2023 14:55 by mr_spock Very disappointing if the sale is made at this price. |
Posted at 18/2/2023 14:59 by raleigh43 I will move back into FUL as a longerm multi bagger once they continue a more agressive openings schedule. Solid well run co and will report bigger sales. No brainer imo |
Posted at 07/2/2023 12:27 by bridggar Lots of buys over the last few sessions - I guess there must be quite a stock overhang given the static price. |
Posted at 02/1/2023 09:10 by raleigh43 How do you think the next few months will go for FUL.Can they thrive in the doom and gloom? |
Posted at 16/12/2022 13:27 by kalai1 Fulham Shore plc, the owner and operator of The Real Greek and Franco Manca restaurant businesses, announced interims for the six months ended 25 September 2022 this morning. Revenues were up 26% to £49.9m, headline EBITDA roughly flat at £10.5m and statutory profit after tax down to a modest £0.3m. The topline is recovering from the Pandemic, the bottom is under pressure from the inflationary cost environment. Valuation is average and not particularly helpful. The near-term macro outlook is the obvious dark cloud looming for consumer cyclical spending. The share price also remains in a 15-month correction and lacks momentum. The business has longer run growth potential, but there is little rush to buy, FUL is a share to monitor for now......from WealthOracle |
Posted at 05/8/2021 14:56 by boonkoh I see that Fulham Shore have changed nomad and broker with immediate effect to Singer.My hunch is maybe a fundraising. They have debt. But they also want to rapidly expand. Not enough existing cash flow to self fund rollout.They did manage to fund raise last August at a 2% premium to share price though. But that was when it was 6.25p... |
Posted at 11/5/2021 18:18 by chinahere 2 weeks and no posts. Who is ramping this?No-one. I reckon it is the potential that is pushing this share. |
Posted at 10/2/2021 10:45 by chinahere Judging by the recent price rise, something is happening in the background here I think. I wouldn't be surprised if we get an RNS about restaurant acquisitions. |
Posted at 08/2/2021 10:17 by boonkoh Cash burn looks to have accelerated recently....! £2m extra net debt since last trading update end of Dec.Some of it will have been rents due end Dec for this quarter. It would have been better if FUL had disclosed their current monthly cash burn projections. |
Posted at 27/2/2020 23:24 by boonkoh Surprised the share price has held up really well.However given the concentration of restaurants in London, I wouldn't be holding.If the covid-19 virus hits the UK in a big way, restaurants will be empty, and FUL will be hit. Should really be trading circa 10p at the moment. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
